Who is sponsoring NCT05455788?

NCT05455788 is sponsored by Assiut University.

What drugs are being tested in NCT05455788?

Interventions in NCT05455788: Aminoglycoside.

What condition does NCT05455788 study?

NCT05455788 studies Prosthetic Valve Endocarditis.

Is NCT05455788 still recruiting?

NCT05455788 is currently status unknown. Last updated 13 July 2022.

Last reviewed 2022-07-13 · How we verify

NCT05455788

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prosthetic Valve Sweing Ring Injection by Antiboitics Can Affect the Rate of Postoperative Infective Endocarditis?

Status unknown Last updated 13 July 2022

What this trial tests

trial testing Aminoglycoside in Prosthetic Valve Endocarditis in 300 participants. Status unknown.

Timeline

1 December 2021

Primary endpoint
1 December 2023

15 December 2023

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	300
Start date	1 December 2021
Primary completion	1 December 2023
Estimated completion	15 December 2023
Sites	1 location across Egypt

Drugs / interventions tested

Aminoglycoside — full drug profile →

Conditions studied

Prosthetic Valve Endocarditis — all drugs for Prosthetic Valve Endocarditis →

Sponsor

Assiut University

Who can join

20 and older, any sex, with Prosthetic Valve Endocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Follow-up of patients undergoing cardiac valve replacements with prosthetic valve after injection of sewing ring of prosthetic valve with aminoglycoside for prevention of infective endocarditis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Aminoglycoside

Trials testing the same drug.

NCT05548283 — Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study · Phase 4 · recruiting
NCT05533593 — Risk Factors and Machine Learning Model for Aminoglycines Related Acute Kidney Injury · completed
NCT02424734 — Safety, Tolerability and Efficacy of Ceftaroline in Paediatrics With Late-Onset Sepsis · Phase 2 · terminated

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05455788 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 13 July 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05455788.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing